H. Ward Wolff
H. Ward Wolff has served as a member of our board of directors since February 2018. Mr. Wolff served as Executive Vice President and Chief Financial Officer of Sangamo Therapeutics, Inc., a biopharmaceutical company, from December 2007 until his retirement in March 2017. From July 2006 until its restructuring in August 2007, Mr. Wolff served as Senior Vice President, Finance and Chief Financial Officer of Nuvelo, Inc., a biopharmaceutical company. From September 2004 until it merged with Amgen Inc. in April 2006, Mr. Wolff was Senior Vice President, Finance and Chief Financial Officer of Abgenix, Inc., a biopharmaceutical company. Prior to joining Abgenix, Mr. Wolff held financial management positions in both public and private emerging growth companies and began his career with Price Waterhouse. Mr. Wolff currently serves on the Board of Directors of Portola Pharmaceuticals, Inc. and Calithera Biosciences, Inc. Mr. Wolff received a B.A. in Economics from the University of California at Berkeley and an M.B.A. degree from Harvard Business School.